You have 9 free searches left this month | for more free features.

Refractory dermatomyositis

Showing 1 - 25 of 8,913

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Dermatomyositis Trial (Interleukin-2)

Not yet recruiting
  • Dermatomyositis
  • (no location specified)
Aug 8, 2022

Dermatomyositis Trial in Nanchang (Lenalidomide)

Not yet recruiting
  • Dermatomyositis
  • Nanchang, Jiangxi, China
    Department of Rheumatology and Clinical Immunology, Jiangxi Prov
Aug 3, 2022

SLE (Systemic Lupus), Sjogren's Syndrome, Systemic Scleroderma Trial in Taiyuan (CD19 targeted CAR-T cells)

Recruiting
  • SLE (Systemic Lupus)
  • +4 more
  • CD19 targeted CAR-T cells
  • Taiyuan, Shanxi, China
    Shanxi Bethune Hospital
Sep 25, 2023

Dermatomyositis, Abatacept Trial in Nanjing (Abatacept)

Recruiting
  • Dermatomyositis
  • Abatacept
  • Nanjing, Jiangsu, China
    The First Affiliated Hospital with Nanjing Medical University
Jun 29, 2021

Polymyositis, Dermatomyositis Trial in Seoul (PN-101)

Enrolling by invitation
  • Polymyositis
  • Dermatomyositis
  • PN-101
  • Seoul, Korea, Republic of
  • +2 more
Jun 10, 2022

Dermatomyositis Trial in Washington (Abatacept)

Completed
  • Dermatomyositis
  • Washington, District of Columbia
    2300 M Street, 9th floor. Medical Faculty Associates, The George
Apr 5, 2022

Dermatomyositis, Juvenile Dermatomyositis Trial in Cleveland (H.P. Acthar Gel)

Completed
  • Dermatomyositis
  • Juvenile Dermatomyositis
  • H.P. Acthar Gel
  • Cleveland, Ohio
    Cleveland Clinic
Sep 10, 2021

Dermatomyositis Trial in Baltimore (Tofacitinib)

Completed
  • Dermatomyositis
  • Baltimore, Maryland
    Johns Hopkins University
Nov 5, 2020

Dermatomyositis, Polymyositis Trial in United States (tocilizumab, )

Completed
  • Dermatomyositis
  • Polymyositis
  • Los Angeles, California
  • +6 more
Oct 8, 2020

Tp-e Interval and Tp-e/QT Ratio in Dermatomyositis and Analysis

Recruiting
  • Dermatomyositis
  • +2 more
    • Zhejiang, Hangzhou, China
      The Third People's Hospital of Hangzhou
    Aug 21, 2023

    Dermatomyositis, Adult Type Trial in New Orleans (Apremilast 30mg)

    Completed
    • Dermatomyositis, Adult Type
    • Apremilast 30mg
    • New Orleans, Louisiana
      Tulane University
    Jul 7, 2021

    Plexin D1 as a Potential Biomarker inPM/DM

    Not yet recruiting
    • Polymyositis
    • Dermatomyositis
    • plexinD1
    • (no location specified)
    Nov 25, 2022

    Dermatomyositis, Adult Type Trial in Xi'an (JAK Inhibitor)

    Recruiting
    • Dermatomyositis, Adult Type
    • JAK Inhibitor
    • Xi'an, Shaanxi, China
      Department of Rheumatology, the First Affiliated Hospital of Xi'
    Jul 15, 2021

    Crohn Disease, Ulcerative Colitis, Dermatomyositis Trial in Hangzhou (CD7 CAR T-cells)

    Recruiting
    • Crohn Disease
    • +4 more
    • CD7 CAR T-cells
    • Hangzhou, Zhejiang, China
      The first affiliated hospital of medical college of zhejiang uni
    Feb 13, 2022

    Inflammatory Myopathy, Idiopathic, Dermatomyositis, Antisynthetase Syndrome Trial in Amsterdam (Immune Globulin Intravenous

    Recruiting
    • Inflammatory Myopathy, Idiopathic
    • +5 more
    • Immune Globulin Intravenous (Human)
    • Placebo
    • Amsterdam, North- Holland, Netherlands
      Department of Neurology, Amsterdam UMC, location AMC
    Apr 14, 2023

    Lymphocyte Subsets of Peripheral Blood in Nonmyopathic

    Recruiting
    • Dermatomyositis
      • Jinan, Shandong, China
        Yanfeng Hou
      Nov 19, 2023

      Dermatomyositis, Adult Type Trial (Itolizumab)

      Not yet recruiting
      • Dermatomyositis, Adult Type
      • (no location specified)
      Aug 3, 2023

      Idiopathic Inflammatory Myopathy, Interstitial Lung Disease Trial in Xi'an (Mycophenolate Mofetil)

      Recruiting
      • Idiopathic Inflammatory Myopathy
      • Interstitial Lung Disease
      • Mycophenolate Mofetil
      • Xi'an, China
        Department of Rheumatology,the First Affiliated Hospital of Xi'a
      Nov 10, 2021

      Dermatomyositis, Polymyositis Trial in Orlando (M5049 high dose, Placebo)

      Recruiting
      • Dermatomyositis
      • Polymyositis
      • M5049 high dose
      • Placebo
      • Orlando, Florida
        HMD Research LLC
      Jan 30, 2023

      Dermatomyositis Trial in DeBary (GLPG3667, Placebo)

      Not yet recruiting
      • Dermatomyositis
      • DeBary, Florida
        Omega Research Consultants
      Jan 13, 2023

      Gastric Mucosal Changes in Patients With Dermatomyositis

      Recruiting
      • Gastric Mucosal Manifestations in Patients With Dermatomyositis
        • Hangzhou, Zhejiang, China
          Second Affiliated Hospital of Zhejiang University School of Medi
        May 30, 2022

        Clinical Analysis of Juvenile Dermatomyositis Patients

        Completed
        • Juvenile Dermatomyositis
        • observation
        • (no location specified)
        Aug 18, 2022

        Polymyositis, Dermatomyositis Trial in Gainesville (Umbilical Cord Lining Stem Cells)

        Active, not recruiting
        • Polymyositis
        • Dermatomyositis
        • Umbilical Cord Lining Stem Cells
        • Gainesville, Florida
          University of Florida
        Jan 31, 2023

        Clinical Responsiveness of Dermatomyositis Using Cutaneous

        Recruiting
        • Dermatomyositis
          • Philadelphia, Pennsylvania
            Hospital of the University of Pennsylvania
          Jan 29, 2022

          Dermatomyositis Trial in Worldwide (Ravulizumab, Placebo)

          Recruiting
          • Dermatomyositis
          • Orange, California
          • +35 more
          Aug 16, 2022